Sweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor
Introduction Gilteritinib is a FLT3 kinase inhibitor approved for FLT3-mutated acute myeloid leukemia (AML). We present a case of febrile neutropenia and neutrophilic dermatosis consistent with Sweet's syndrome (SS). Case history A 55-year-old woman presented with fever and skin lesions after 4...
Salvato in:
Autori principali: | , , , , |
---|---|
Natura: | Libro |
Pubblicazione: |
Greater Baltimore Medical Center,
2020-05-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
Collocazione: |
A1234.567 |
---|---|
Copia 1 | Disponibile |